Juvenescence

Multiple aging-focused assets · Multiple

Phase 1

Mechanism

Multiple aging-focused assets

Intervention class

Holding co / multi-asset

Indication

Multiple

Stage

Phase 1

Evidence

human

Funding

$220M+

Backers

Various

Overview

Aggregator/builder of longevity drug programs across small molecules, regenerative medicine and AI discovery. Broad exposure to the field.

Company website / source ↗ Open the interactive map →

◢ Boom-cycle briefing

Get ahead of the next biotech boom.

New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.

Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.